Solid dosage guide released

ISPE has released Oral Solid Dosage (OSD) Forms Baseline Guide, Second Edition, at its annual meeting in San Diego this week. The FDA-reviewed publication updates content from the original work to current industry standards, practices, and regulatory requirements.

The not-for-profit association says the guide addresses the latest interpretation of GMP requirements, as well as a risk-based approach to regulatory compliance related to the design, construction, and validation of solid dosage manufacturing facilities. A non-theoretical approach gives readers guidance on solving problems and addressing regulatory inspections and compliance issues.

Topics include regulatory philosophy, product protection, process support and utilities, risk-based approaches to commissioning and qualification, and cost factors in oral solid dose manufacturing.

- here's the table of contents 

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.